Description
SNS-032 is a CDK inhibitor with selectivity for CDK2 and CDK7/9. In chronic lymphocytic leukemia cells, SNS-032 induces apoptosis in vitro. It is used in combination with AT-7519 to exhibit anticancer effects in cervical cancer, inhibiting cancer cell migration in vitro and inhibiting tumor growth in a human xenograft tumor model.